Back to Journals » OncoTargets and Therapy » Volume 11

Clinical benefit from afatinib in an advanced squamous cell lung carcinoma patient harboring HER2 S310Y mutation: a case report

Total article views   HTML views PDF downloads Totals
9,148 Dovepress* 7,615+ 868 8,483
PubMed Central* 1,533 361 1,894
Totals 9,148 1,229 10,377
*Since 5 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed and Google Scholar